Cure My Disease

Don't miss your cure!

 Log in / Sign up

Green tea compound EGCG put to the test for clearer, more hydrated skin

NCT ID NCT07725900

Symptom relief Sponsor: Naniek Widyaningrum Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 24, 2026 · Last updated Jul 28, 2026 · Updated 2 times

Summary

This large-scale trial is testing whether a topical cream containing epigallocatechin gallate (EGCG), a compound from green tea, can reduce facial redness (erythema), dark spots (melanin), and improve skin moisture. Over 300 participants will apply the cream twice daily for 84 days, while a smaller control group receives no product. Researchers will measure changes using specialized skin sensors to see if the cream delivers visible improvements.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a topical skincare cream containing epigallocatechin gallate (EGCG) from green tea
What this could lead to
If effective, this cream could offer a natural, over-the-counter option for reducing facial redness, dark spots, and improving skin hydration.
What could go wrong
This is an early-to-mid-stage trial with a quasi-experimental design, not a randomized controlled trial. Results may not generalize, and individual skin reactions are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2/3

Runs two stages together: whether the treatment works, then large-scale confirmation.

Participants

300 people

The number who actually took part.

Started

Dec 2025

Finished

Jun 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 40 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Willing to use MB LuxuryⓇ products alone for 84 days * Willing to fill out an informed consent * Aged 20-40 years * Not currently experiencing skin irritation * Not having a history of allergies to MB LuxuryⓇ product components Exclusion Criteria: * Individuals under 20 years of age and over 40 years of age * Currently experiencing skin irritation or disorders * Have a history of allergies to MB LuxuryⓇ product components.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dry skin are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Erythema Hyperpigmentation hyperpigmentation of the skin

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dry skin Erythema Hyperpigmentation

Contacts and locations

Locations

  • Universitas Islam Sultan Agung

    Semarang, Central Java, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.